Prostate Cancer - Results from #1380

The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis. February 13, 2024

Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target. February 13, 2024

Local therapies for oligometastatic hormone-sensitive prostate cancer. February 12, 2024

Representation Matters: Trust in Digital Health Information Among Black Patients With Prostate Cancer. February 12, 2024

Safety and effectiveness of the radium-223-taxane treatment sequence in patients with metastatic castration-resistant prostate cancer in a global observational study (REASSURE). February 12, 2024

A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC). February 12, 2024

A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis. February 12, 2024

Gender-affirming hormone therapy in transgender women and risk of prostate cancer: pathophysiological mechanisms and clinical implications. February 12, 2024

How can we identify Extraprostatic Extension (EPE) Before Surgery? The Use of a Preoperative Prostate MRI EPE Scoring System to Assess Post-Prostatectomy Locally Advanced Prostate Cancer. February 9, 2024

Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging: A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial. February 9, 2024

Incidence of prostate cancer in transgender women in the US: a large database analysis. February 9, 2024

Urinary volatile organic compounds in prostate cancer biopsy pathologic risk stratification using logistic regression and multivariate analysis models. February 9, 2024

Use of rectal balloon spacer in patients with localized prostate cancer receiving external beam radiotherapy. February 9, 2024

Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment. February 8, 2024

Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer. February 8, 2024

Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer. February 8, 2024

Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer. February 8, 2024

Association of extended core sampling with delayed intervention and pathologic outcomes for active surveillance patients: A population-based analysis. February 8, 2024

Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer. February 8, 2024

Deep learning-based automated pipeline for blood vessel detection and distribution analysis in multiplexed prostate cancer images. February 8, 2024

Page 70 of 1436